Chamath Palihapitiya backed ProKidney's SPAC merger in July 2025.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Chamath Palihapitiya backed ProKidney's SPAC merger in July 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Chamath Palihapitiya
Sri Lankan-born Canadian-American businessman and CEO of Social Capital
Coverage
Newest first; wire copies grouped- BarchartProKidney Just Set a New 52-Week High. Should You Buy, Sell, or Hold PROK Stock Here? Chronic kidney disease (CKD) is a silent epidemic. In this high-stakes space, biotechnology companies focused on